However, the role of the MLL4 complex beyond the steatosis step has not yet been investigated and the identity of its target genes/enhancers associated with NASH progression as well as the transcription factors that recruit the MLL4 complex to these genes remain to be further defined. This evidence concerns the gene KMT2D and metabolic dysfunction-associated steatohepatitis.